iCAD Reports Financial Results for Third Quarter Ended September 30, 2023
November 13, 2023 16:01 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023
October 30, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast...
iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta
October 23, 2023 08:01 ET
|
iCAD, Inc.
NASHUA, N.H., Oct. 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions announced today that Elekta...
Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment
August 16, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 16, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Health...
iCAD Reports Financial Results for Second Quarter Ended June 30, 2023
August 14, 2023 16:01 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported its...
iCAD and Google Health Expand Integration of Google’s AI Technology with iCAD’s ProFound Breast Health Suite for 2D Mammography for Use as Independent Reader
August 14, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it signed...
iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023
July 31, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., July 31, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it will...
iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice
July 18, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., July 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it has...
iCAD’s “ProFound Insights, ProFound Impact” Webinar Series to Feature Cleveland Clinic
July 12, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., July 12, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its...
iCAD Offers ROI Analysis Based on Real-World Results from its ProFound Breast AI Suite at AHRA Annual Meeting
July 10, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., July 10, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced it is...